ANNX Annexon Inc

Price (delayed)

$5.26

Market cap

$997.19M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

$821.54M

?
Relative Growth: Rel. Growth: 7
Relative Strength: Rel. Strength: 83
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders of the body, brain and eye. The ...

Highlights
Annexon's EPS has increased by 12% YoY and by 5% QoQ
Annexon's debt has decreased by 11% YoY and by 3.1% from the previous quarter
Annexon's quick ratio has decreased by 13% from the previous quarter and by 2.7% YoY
The equity has declined by 9% since the previous quarter and by 7% year-on-year

Key stats

What are the main financial stats of ANNX

ANNX stock price

How has the Annexon stock price performed over time
Intraday
-1.31%
1 week
-6.07%
1 month
-6.57%
1 year
102.31%
YTD
4.78%
QTD
-7.88%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$210.56M
Net income
-$202.67M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 8% YoY and by 3.2% QoQ
The company's operating income fell by 4.7% YoY and by 2.7% QoQ

Price vs fundamentals

How does ANNX's price correlate with its fundamentals

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
4.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 12% YoY and by 5% QoQ
The P/B is 157% higher than the 5-year quarterly average of 1.8 and 29% higher than the last 4 quarters average of 3.6
The equity has declined by 9% since the previous quarter and by 7% year-on-year

Efficiency

How efficient is Annexon business performance
The ROE has dropped by 50% year-on-year and by 4% since the previous quarter
ANNX's ROA is down by 37% YoY and by 4% QoQ
The return on invested capital has declined by 35% since the previous quarter

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's quick ratio has decreased by 13% from the previous quarter and by 2.7% YoY
Annexon's current ratio has decreased by 13% from the previous quarter and by 2.5% YoY
Annexon's debt is 87% less than its equity
Annexon's debt has decreased by 11% YoY and by 3.1% from the previous quarter
The equity has declined by 9% since the previous quarter and by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.